Published in Clin Exp Immunol on September 01, 2003
Cytotoxicity of activated natural killer cells against pediatric solid tumors. Clin Cancer Res (2010) 2.51
IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J Immunol (2010) 2.12
Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect Immun (2009) 1.13
Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis. Cancer Res (2008) 1.08
Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development. Br J Cancer (2010) 1.03
Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis. Cancer Res (2008) 1.00
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells. Cancer Immunol Immunother (2011) 0.99
Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression. Front Oncol (2013) 0.88
Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience. J Biomed Biotechnol (2010) 0.85
Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice. Int J Cancer (2011) 0.82
Possible prognostic role of IL-17R in osteosarcoma. J Cancer Res Clin Oncol (2007) 0.81
Expression of Th1- Th2- and Th17-associated cytokines in laryngeal carcinoma. Oncol Lett (2016) 0.75
Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma. Oncol Lett (2017) 0.75
Human IL-17: a novel cytokine derived from T cells. J Immunol (1995) 6.65
IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol (1998) 5.79
Interleukin-17 promotes angiogenesis and tumor growth. Blood (2002) 4.90
Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol (1983) 4.38
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood (2002) 3.17
IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol (1999) 2.29
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res (1999) 2.23
Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum (2000) 2.13
Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine (1997) 1.87
Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin Diagn Lab Immunol (2001) 1.54
The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes. J Immunol (1988) 1.47
On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer (1997) 1.42
Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol (2002) 1.35
Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone (1995) 1.26
Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene. Anticancer Res (2000) 1.04
Molecular analysis of the hematopoiesis supporting osteoblastic cell line U2-OS. Exp Hematol (2000) 0.94
Human osteosarcoma cells, tumorigenic in nude-mice, express beta(1)-integrins and low-levels of alkaline-phosphatase activity. Int J Oncol (1993) 0.88
Cancer immunotherapy with interleukin-2-activated natural killer cells. Mol Biotechnol (2002) 0.86
Human osteosarcoma cell susceptibility to natural killer cell lysis depends on CD54 and increases after TNF alpha incubation. FEBS Lett (1997) 0.86
Long term activation of natural killer cells results in modulation of beta 1-integrin expression and function. J Immunol (1994) 0.85
Genetically modified HLA class I molecules able to inhibit human NK cells without provoking alloreactive CD8+ CTLs. J Immunol (2002) 0.82
NK binding capacity and lytic activity depend on the expression of ICAM-1 on target bone tumours. Int J Oncol (1999) 0.81
VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Exp Hematol (1995) 0.81
Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines. J Bone Miner Res (1996) 0.80
Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha. Anticancer Res (1992) 0.79
Clinical outcome of extramedullary plasmacytoma. Haematologica (2000) 3.27
Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med (2000) 1.68
Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin Diagn Lab Immunol (2001) 1.54
Perihepatic lymphadenopathy in chronic hepatitis C: a complementary diagnostic element? J Gastroenterol Hepatol (2000) 1.46
Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum (2000) 1.41
High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford) (2001) 1.40
Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum (1998) 1.39
Transplantation of chondrocytes seeded on a hyaluronan derivative (hyaff-11) into cartilage defects in rabbits. Biomaterials (2001) 1.35
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage (2005) 1.22
Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis Cartilage (2002) 1.13
Chemokine production by human chondrocytes. J Rheumatol (1999) 1.12
Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim Biophys Acta (2011) 1.11
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett (1999) 1.07
Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement. Arthritis Rheum (2001) 1.06
Vascular endothelial growth factor production in polymyalgia rheumatica. Arthritis Rheum (2000) 1.06
The human anterior cruciate ligament: histological and ultrastructural observations. J Anat (1992) 1.05
Elevated interleukin-8 serum concentrations in beta-thalassemia and graft-versus-host disease. Blood (1993) 1.05
Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Minerva Med (2011) 1.04
Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology (1997) 1.04
The detached osteochondral fragment as a source of cells for autologous chondrocyte implantation (ACI) in the ankle joint. Osteoarthritis Cartilage (2005) 1.03
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Ann Oncol (2009) 1.01
Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged >/=90 y. Am J Clin Nutr (2000) 1.00
Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol (1999) 0.99
A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B. Clin Exp Immunol (1999) 0.98
Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol (1999) 0.98
Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy. Clin Exp Immunol (1992) 0.98
Combined therapy of localized Ewing's sarcoma of bone: analysis of results in 100 patients. Int J Radiat Oncol Biol Phys (1990) 0.97
Basic fibroblast growth factor enhances in vitro mineralization of rat bone marrow stromal cells grown on non-woven hyaluronic acid based polymer scaffold. Biomaterials (2001) 0.96
Endothelin-1 in idiopathic pulmonary fibrosis. J Clin Pathol (1995) 0.96
Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. Clin Exp Immunol (1990) 0.96
Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol (1989) 0.96
[Extramedullary plasmocytoma (EMP) of the head and neck: a series of 22 cases]. Acta Otorhinolaryngol Ital (1995) 0.95
Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci (Lond) (2001) 0.95
Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter. Eur J Biochem (2001) 0.95
Evaluation of an automated extraction system in combination with Affigene CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test. J Virol Methods (2008) 0.94
In vitro cultured stromal cells from human tonsils display a distinct phenotype and induce B cell adhesion and proliferation. Eur J Immunol (1996) 0.93
Nuclear damages and oxidative stress: new perspectives for laminopathies. Eur J Histochem (2012) 0.93
In vitro immunotoxicity of +/- 2'-deoxy-3'-thiacytidine, a new anti-HIV agent. Clin Exp Immunol (1993) 0.93
Osteogenesis of large segmental radius defects enhanced by basic fibroblast growth factor activated bone marrow stromal cells grown on non-woven hyaluronic acid-based polymer scaffold. Biomaterials (2002) 0.91
Analysis of mesenchymal stem cells grown on a three-dimensional HYAFF 11-based prototype ligament scaffold. J Biomed Mater Res A (2005) 0.91
Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum (1996) 0.91
Chemokine expression by subchondral bone marrow stromal cells isolated from osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Clin Exp Immunol (1999) 0.91
Human Achilles tendon: morphological and morphometric variations as a function of age. Foot Ankle (1991) 0.90
Lymphocytotoxicity test against rabbit hepatocytes in chronic liver diseases. Gut (1978) 0.90
Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis. Clin Exp Immunol (1998) 0.90
Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B. Clin Exp Immunol (1981) 0.90
Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol (1999) 0.90
Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation. Breast Cancer Res Treat (1999) 0.89
Use of poligonal windows for physical discrimination among mononuclear subpopulations in flow cytometry. J Immunol Methods (1987) 0.89
The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell Immunol (1992) 0.89
Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome? Thorax (1990) 0.89
An elevated number of differentiated osteoblast colonies can be obtained from rat bone marrow stromal cells using a gradient isolation procedure. Connect Tissue Res (2001) 0.88
Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO "Pluricell System". Bone Marrow Transplant (2005) 0.88
Acute phase proteins in chronic and malignant liver diseases. Liver (1988) 0.88
Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria. Minerva Med (2008) 0.88
A fluorescent in situ hybridization method in flow cytometry to detect HIV-1 specific RNA. J Immunol Methods (1996) 0.88
Clinical applications and biosafety of human adult mesenchymal stem cells. Curr Pharm Des (2012) 0.87
Age-dependent decreases of NK cell phosphoinositide turnover during spontaneous but not Fc-mediated cytolytic activity. Int Immunol (1998) 0.87
A study of cupremia in a group of elderly diabetics. Acta Diabetol Lat (1983) 0.87
Psychosocial integration of adolescents and young adults with thalassemia major. Ann N Y Acad Sci (1998) 0.87
Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells. Br J Haematol (2001) 0.87
Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes: Maintenance of differentiated phenotype under defined culture conditions. Osteoarthritis Cartilage (2002) 0.86
Human osteosarcoma cell susceptibility to natural killer cell lysis depends on CD54 and increases after TNF alpha incubation. FEBS Lett (1997) 0.86
Cellular response and anti-HBs synthesis in vitro after vaccination with yeast-derived recombinant hepatitis vaccine. Vaccine (1992) 0.86
Interleukin-12 induces efficient lysis of natural killer-sensitive and natural killer-resistant human osteosarcoma cells: the synergistic effect of interleukin-2. Scand J Immunol (2000) 0.86
Analysis with OKT monoclonal antibodies of T-lymphocyte subsets present in blood and liver of patients with chronic active hepatitis. Liver (1984) 0.86
Polyamine biosynthesis as a target to inhibit apoptosis of non-tumoral cells. Amino Acids (2007) 0.86
IgG subclass distribution of anti-HBs antibodies following vaccination with cDNA HBsAg. J Immunol Methods (1992) 0.86
A molecular and histological characterization of cartilage from patients with Morquio syndrome. Osteoarthritis Cartilage (2007) 0.85
Chemokine production by peripheral blood mononuclear cells in elderly subjects. Mech Ageing Dev (2000) 0.85
Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mech Ageing Dev (2000) 0.85
Down-modulation of chemokine receptor cartilage expression in inflammatory arthritis. Rheumatology (Oxford) (2003) 0.85
Regular moderate intensity physical activity and blood concentrations of endogenous anabolic hormones and thyroid hormones in aging men. Mech Ageing Dev (2001) 0.85
Radioimmunoassay for hepatitis B 'e' antigen and antibody: correlations with viral replication and prognostic value. Vox Sang (1981) 0.85
Clinical picture of endemic cretinism in central Apennines (Montefeltro). Thyroid (1992) 0.85
Spermine causes caspase activation in leukaemia cells. FEBS Lett (1998) 0.84
Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35. Clin Exp Immunol (2000) 0.84
Topoisomerase-II-mediated DNA cleavage within the human ribosomal genes. Biochem Biophys Res Commun (1995) 0.84
Differential expression of IL-1 and TNF receptors in inflammatory arthritis and osteoarthritis. Boll Soc Ital Biol Sper (1996) 0.83
Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease. Haematologica (1995) 0.83
Perforins in human cytolytic cells: the effect of age. Mech Ageing Dev (1996) 0.83
p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells. Biochem J (1999) 0.83
Different IL-8 production by T and NK lymphocytes in elderly subjects. Mech Ageing Dev (2001) 0.83
TNF-alpha but not IL-1 and IL-6 modifies the susceptibility of human osteosarcoma cells to NK lysis. Int J Oncol (1998) 0.83
Standardization of a micro-cytotoxicity assay for human natural killer cell lytic activity. J Immunol Methods (1994) 0.83